Skip to main

Medicines Advisory Statements Specification 2017

No longer in force
Administered by
  • Department of Health, Disability and Ageing

This item is authorised by the following title:

Latest version
F2017L0085730 June 2017 - 28 February 2019

For transitional provisions relating to the repeal of this specification, see section 8 of the Therapeutic Goods (Medicines Advisory Statements) Specification 2019.


Details

Title ID
F2017L00857
Registered
30 June 2017
Effective
30 June 2017 - 28 February 2019
Type
Principal

Any available explanatory material for this instrument can be found on the Downloads tab

Date repealed
01 March 2019

For transitional provisions relating to the repeal of this specification, see section 8 of the Therapeutic Goods (Medicines Advisory Statements) Specification 2019.

Tabling

When documents are presented to the Australian Parliament for scrutiny, they are said to have been tabled.

House of Representatives

  • Legislative Instrument
    08 August 2017
  • Explanatory Statement
    08 August 2017

Senate

  • Legislative Instrument
    08 August 2017
  • Explanatory Statement
    08 August 2017